Revenue Guidance

 
News Articles for Revenue Guidance top ^
- Revenue Increases to $75.3 million, up 13% from Q3'13 - Home Revenue Increases to $40.4 million, up 20% from Q3'13 - Company Raises Full-Year 2014 Revenue Guidance to be between $296 and $298 million - New Data Demonstrates Significant Improvement in Mortality, Hospitalization, and Patient Dropout with Home Hemodialysis when Compared with Peritoneal Dialysis LAWRENCE, Mass.
Sign-up for NxStage Reports Record Third Quarter 2014 Financial Results And Raises Full-Year Revenue Guidance investment picks
Full-Year 2014 Home Revenue Projected to Increase Approximately 18% LAWRENCE, Mass.
Sign-up for NxStage Increases Revenue Guidance for the Fourth Quarter and Full-Year 2014 investment picks
2014/10/27
AMSTERDAM, The Netherlands, Oct.
Sign-up for Tornier Announces Third Quarter 2014 Revenue and Increases 2014 Revenue Guidance investment picks
INCLINE VILLAGE, Nev.
Sign-up for PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million investment picks
GNCC Capital, Inc. (OTC:GNCP) (“The Company”) updates on its operations and provides revenue guidance on its operations as follows: Gold Coast Gaming Corp (“Gold Coast”) subsidiary Revenues (Actual): August, 2014: Actual Gross Gaming - $664,510 September, 2014: Actual Gross Gaming - $830,203 October, 2014: Actual Gross Gaming - $1,027,255 Revenues and profits for both August and September, 2014 will be accounted for in the Company’s financial year ended on September 30, 2014 as GNCC’s acquisition of Gold Coast was effective August 11, 2014.
Sign-up for GNCC Capital, Inc. Provides Operational Update and Revenue Guidance investment picks
http://media.marketwire.com/attachments/200501/200497_SciCloneLogo-Color-R.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167576&ProfileId=051205&sourceType=1 FOSTER CITY, CA --
Sign-up for SciClone Provides 2014 Financial Update and 2015 Revenue Guidance investment picks
2015/1/20
Subhead of release should read: Company to host a Conference Call and Webcast on Wednesday, February 25th beginning at 10:00 a.m. EST to report 4Q and FY2014 Financial Results (instead of Monday, February 25th). Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that based on a preliminary review of 2014 fourth quarter results it expects Net Revenue to exceed FY2014 guidance.
Sign-up for CORRECTING and REPLACING Pernix Therapeutics Exceeds 2014 Revenue Guidance: Delivers FY2014 Net Revenue In Excess of $120 Million investment picks
WILMINGTON, Del., Nov.
Sign-up for InterDigital Issues Revenue Guidance for Fourth Quarter 2014 investment picks
Ascent Solar Technologies, Inc. (“Ascent”) (NASDAQ:ASTI), a manufacturer of state-of-the-art, flexible thin-film photovoltaic modules, integrated into off-grid applications and the company’s EnerPlex™ series of consumer products, announced today the Company’s third quarter results ended September 30, 2014.
Sign-up for Ascent Solar Announces Q3 Results and Reiterates Full Year Revenue Guidance of $5 - $6 Million Dollars investment picks
2015/1/12
SHENZHEN, China , Jan.
Sign-up for Mindray Announces Preliminary 2014 Operating Results and 2015 Net Revenues Guidance investment picks
http://media.marketwire.com/attachments/201202/40192_SmithMicroSoftware.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168950&ProfileId=051205&sourceType=1 ALISO VIEJO, CA --
Sign-up for Smith Micro Reports Preliminary Q4 2014 Revenue and Profits; Provides Revenue Guidance for Fiscal 2015 investment picks
Fluidigm Corporation (NASDAQ:FLDM) today announced total revenue for the fourth quarter of 2014 is expected to be approximately $33.4 million based on preliminary, unaudited financial data.
Sign-up for Fluidigm Announces Preliminary Fourth Quarter 2014 Revenue and Issues 2015 Revenue Guidance investment picks
FORT WORTH, Texas, Jan.
Sign-up for Tandy Leather Factory, Inc. Beats 2014 Revenue Guidance With Strong December Sales Gain of 18% investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Revenue Guidance
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Revenue Growth  |  Next: Revenue Guidance for the Year